Maufrais C, Millet GP, Schuster I, Rupp T, Nottin S. Progressive and biphasic cardiac responses during extreme mountain ultramarathon. Am J Physiol Heart Circ Physiol 310: H1340 -H1348, 2016. First published February 26, 2016 doi:10.1152/ajpheart.00037.2016.-Investigations on the cardiac function consequences of mountain ultramarathon (MUM) Ͼ100 h are lacking. The present study assessed the progressive cardiac responses during the world's most challenging MUM (Tor des Géants; Italy; 330 km; 24,000 m of cumulative elevation gain). Resting echocardiographic evaluation of morphology, function, and mechanics of left and right ventricle (LV and RV) including speckle tracking echocardiography was conducted in 15 male participants (46 Ϯ 13 yr) before (pre), during (mid; 148 km), and after (post) the race. Runners completed the race in 126 Ϯ 15 h. From pre to post, the increase in stroke volume (SV) (103 Ϯ 19 vs. 110 Ϯ 23 vs. 116 Ϯ 21 ml; P Ͻ 0.001 at pre, mid, and post) was concomitant to the increase in LV early filling (peak E; 72.9 Ϯ 15.7 vs. 74.6 Ϯ 13.1 vs. 82.1 Ϯ 11.5 cm/s; P Ͻ 0.05). Left and right atrial end-diastolic areas, RV end-diastolic area, and LV enddiastolic volume were 12-19% higher at post compared with pre (P Ͻ 0.05). Resting heart rate and LV systolic strain rates demonstrated a biphasic adaptation with an increase from pre to mid (55 Ϯ 8 vs. 72 Ϯ 11 beats/min, P Ͻ 0.001) and a return to baseline values from mid to post (59 Ϯ 8 beats/min). Significant correlations were found between pre-topost percent changes in peak E and LV end-diastolic volume (r ϭ 0.63, P Ͻ 0.05) or RV (r ϭ 0.82, P Ͻ 0.001) or atrial end-diastolic areas (r ϭ 0.83, P Ͻ 0.001). An extreme MUM induced a biphasic pattern of heart rate in parallel with specific cardiac responses characterized by a progressive increase in diastolic filling, biventricular volumes, and SV. IT IS WELL DOCUMENTED THAT prolonged intense exercise, such as a marathon or Ironman triathlon, transitorily alters cardiac function (7, 13, 20, 22, 23, 28, 42) . A range of 3-15 h exercising induces transient left ventricular (LV) global systolic (20, 42) and diastolic (7, 23, 28) dysfunctions. This phenomenon, named exercise-induced cardiac fatigue (EICF), is generally associated with the release of biochemical markers of myocardial damage (13, 22) .
IT IS WELL DOCUMENTED THAT prolonged intense exercise, such as a marathon or Ironman triathlon, transitorily alters cardiac function (7, 13, 20, 22, 23, 28, 42) . A range of 3-15 h exercising induces transient left ventricular (LV) global systolic (20, 42) and diastolic (7, 23, 28) dysfunctions. This phenomenon, named exercise-induced cardiac fatigue (EICF), is generally associated with the release of biochemical markers of myocardial damage (13, 22) .
Whereas the impact of races such as marathons or Ironman triathlons has been extensively described, few studies have explored cardiac function after ultraendurance exercise. After 24 -26 h of exercise, previous studies observed a depressed diastolic function (5, 24, 29, 30, 35) . However, conflicting results were observed on systolic function because ejection fraction (EF) was either decreased (24, 29, 35) or unchanged (5, 30) . Recently, we evaluated the cardiac function consequences of a mountain ultramarathon (MUM) (i.e., 38 Ϯ 5 h). It is important to note that an important decrease in velocity (e.g., large deceleration) has been reported in the MUM of the present study (34) , caused by the combination of extreme distance and sleep deprivation, leading to a very low relative intensity in the final part of the race. This MUM is different from shorter-endurance events like a marathon or ironman triathlon. Moreover, a strong body of evidence has suggested that MUMs induce a progressive plasma volume (PV) expansion (16, 33) . The specific features of this type of event may be responsible for the specific alterations induced by MUMs. In opposition to exercise of shorter duration, we observed specific cardiovascular responses characterized by no alteration in LV function (39) . However, investigations on MUMs Ͼ100 h are lacking, and the time course of the cardiac function during such races is less known because measurements during a competitive event are difficult (39) . Of note, a biphasic change in heart rate (HR) during a 24-h ultraendurance event was reported (17, 18, 31) , suggesting that myocardial function might potentially be altered in a nonlinear progressive manner.
In this context, the aim of the present study was to evaluate for the first time the acute cardiac consequences of the world's most challenging MUM. We aimed to assess the progressive cardiac responses during and after the race by echocardiographic evaluation conducted pre-, mid-, and postrace. To obtain insight into LV intrinsic regional myocardial function, we used 2D Speckle Tracking Echocardiography (STE) to assess regional LV (2, 10) and right ventricular (RV) strains (15) . We hypothesized that, due to the specific physiological processes of MUMs, especially PV expansion, several days of running in mountains would induce specific and progressive alterations of cardiac function.
MATERIALS AND METHODS
Study population. Thirty-four male runners participating in the Tor des Géants (TDG) in 2012 were initially recruited through advertisements on the official website of the race. The finishers-to-starters ratio for our study sample was 64%, and several runners declined undergoing testing at the midsession for not losing time. Therefore, we report here the data of 15 subjects (mean age: 46 Ϯ 13 yr old; height: 176 Ϯ 5 cm; body mass: 72.2 Ϯ 6.4 kg) who completed all three echocardiographic evaluations at pre-, mid-, and postrace. The protocol was approved by the local ethics committee and carefully explained to the runners. None of the subjects had clinical or anamnestic evidence of cardiac diseases or hypertension. Written informed consent was provided and signed by all participants.
Experimental protocol. TDG is considered as the world's most challenging MUM; it entails running or walking a race of 330 km with considerable cumulative elevation gain (i.e., the sum of every elevation gain throughout the entire race, ϩ24,000 m) within 150 h (for further details, see www.tordesgeants.it). In a longitudinal study design, subjects were tested three times: before [Courmayeur, Italy, altitude 1,224 m (pre)], during [Donnas, Italy, altitude 322 m, 148.7 km (mid)], and after the race [Saint-Rhémy-en-Bosses, altitude 1,519 m, 300 km (post), the race having been stopped 30 km before the intended finish line due to rough weather] (Fig. 1) . To evaluate the flat equivalent speed, we calculated a flat equivalent distance with the following formula: flat equivalent distance ϭ distance (km) ϩ positive elevation change (m)/100. We used the flat equivalent speed because this parameter takes into account the elevation gain, an important feature of MUM. Body mass was measured with a balance beam scale. None of the subjects exercised or consumed alcohol or caffeine during the 24 h before the preassessment. The timing between cessation of running and echocardiographic acquisitions was similar for the mid and post measurements (30 Ϯ 17 and 36 Ϯ 17 min, respectively, not significant). Measurements were taken in the same indoor quiet conditions. The subjects were allowed to consume food and fluid ad libitum during the race, but the intake was not monitored due to logistical constraints and the difficulty to access the runners on mountainous path along the MUM.
Echocardiographic data acquisition. All cardiac measurements were made in resting conditions. Echocardiography, including standard parameters, tissue Doppler, and STE, were obtained in the left lateral decubitus position with a commercially available system (Vivid Q; GE Healthcare, Horten, Norway) with a 3.5-MHz sector scanning electronic transducer. Examination of the inferior vena cava (IVC) was performed in the supine position. We recorded cine loops in parasternal short-axis and apical four-chamber views during a 2-to 3-s breath-holding period at the end of breathing out. 2D grayscale harmonic images were obtained at a rate of 60 -90 frames/s, and color tissue velocity images were acquired at a rate of 120 -140 frames/s. Images were acquired in cine loops triggered by the QRS complex and saved for offline analysis, which was performed using dedicated software (EchoPac 6.0; GE Healthcare).
2D and tissue doppler echocardiography. M-mode measurements were obtained in the parasternal long-axis view, according to the recommendations of the American Society of Echocardiography (14) . The LV end-diastolic volume (EDV) and end-systolic volume (ESV) were assessed from the four-chamber view. The LV EF was calculated from LV volumes [i.e., EF ϭ (EDV Ϫ ESV)/EDV ϫ 100]. The RV, left and right atrium (LA and RA, respectively) areas were assessed on an apical four-chamber view. The RV fractional area change (FAC) was calculated using RV end-diastolic and -systolic areas (EDA and ESA, respectively), with the following formula: FAC ϭ (RV EDA -RV ESA)/(RV EDA)*100. The tricuspid annular plane systolic excursion (TAPSE) estimates RV systolic function by measuring the level of systolic excursion of the lateral tricuspid valve annulus toward the apex in the four-chamber view. Pulsed Doppler LV (peaks E and A) and RV (peaks E t and At) inflows and pulmonary venous flow (peaks S, D, and A) were recorded from the apical four-chamber view. Stroke volume (SV), HR, and cardiac output were calculated from an apical five-chamber view. Systemic vascular resistances (SVR) were obtained as mean arterial pressures divided by cardiac output. IVC diameters were measured at the end of inspiration and end of expiration in a subxiphoid location in the longitudinal axis 2 cm distal to the IVC hepatic vein junction where the anterior and posterior wall of the IVC are easily visualized, and lie parallel to each other. Diameters were measured by calipers using the trailing edge-to-the leading edge technique. We used pulmonary venous flow and IVC data to estimate the venous return alterations during and after the race (11, 32) .
We assessed wall motion velocities at the mitral annulus level on the septal and lateral walls. Peak myocardial systolic velocity and early and late diastolic velocities were assessed and averaged from septal and lateral walls ͑S mean E mean, and A mean, respectively). For the RV, we assessed wall velocities ͑S RV, E RV, and A RV) at the tricuspid annulus level on the free wall. To assess LV intrinsic relaxation properties, we used indexes such as E mean from tissue Doppler imaging (21), longitudinal strain rate (40) , or untwisting rate (6) from STE.
Speckle tracking echocardiography. Care was taken to ensure that the basal short-axis plane contained the mitral valve and that the apical plane was acquired distally to the papillary muscle with the LV as circular as possible and proximal to the level with luminal obliteration at end systole (37) . Analysis of LV strains and peak twist was conducted as previously described (25) . After manually tracing the endocardial border on the end-systolic frame of the 2D sequence, the software automatically tracked, i.e., followed in time over the cardiac cycle, myocardial motion. Whenever the software signaled poor tracking efficiency, the observer readjusted the endocardial traceline, the width of the region of interest, or both until a better tracking score could be obtained. Even if the process was approved, the observer checked that the software appropriately tracked the tissue. LV longitudinal strains were assessed from an apical four-chamber view, and circumferential strains, rotations, and rotational rate were assessed from short-axis views at basal and apical levels. To check that the same locations were used both at pre-, mid-, and postrace for each runner, we printed the 2D images obtained on the different views at prerace. Net LV peak twist was calculated as the instantaneous difference between LV apical and LV basal rotations. RV longitudinal strains were assessed on the free wall (3 segments), from an apical four-chamber view. 2D strain data were processed with a specific toolbox (Scilab 4.1, Consortium Scilab; INRIA-ENPC, Paris, France) (19, 25, 39) . For temporal analysis, this software adjusted all strain variables for intersubject differences in HR and frame rate acquisition. The time sequence was normalized to the percentage of systolic duration (i.e., aortic valve closure represented 100% of systolic duration) using linear interpolation to obtain one point at each percentage of the cardiac cycle from 1 to 200% of systolic duration. After normalization, software averaged the data from three to five cardiac cycles and performed the detection of peak strain and strain rate events and their timing (expressed as percentage of systolic duration).
The intra-and interobserver reproducibility of the evaluation of strains by STE was previously assessed in our laboratory (4) , and the coefficient of variation was 3.1 and 5.9%, respectively, for strain and 14.2 and 16.6%, respectively, for peak twist. In general, the echogenicity of our athletes was very good, and thus the feasibility of evaluation of strains was high: 100% for left ventricular longitudinal circumferential strains and apical rotation, 98% for apical rotation, and 89% for longitudinal right ventricular strain.
Statistical analysis. All values in the text and Tables 1-4 are expressed as means Ϯ SD. The statistical analysis was performed using specific software (Statview 5.0, Cary, NC). Data were analyzed using a one-way repeated-measures analysis of variance (i.e., ANOVA), and post hoc tests were done (Bonferroni with the P value corrected as 0.016) when appropriate. Relations between pre-mid and mid-post percentage changes of strain rates with percentage changes for HR and relations between pre-post percentage changes of LV EDV, peak E, LA EDA, and IVC diameter with percentage changes for SV were examined using Pearson correlation. Statistical significance for the ANOVA was assumed at P Ͻ 0.05.
RESULTS
Personal data of the trailers are exposed in Table 1 . The runners completed the first part of the race in 47 h and 45 min (range: 35 h and 37 min to 56 h and 31 min) and finished the race in 126 h and 02 min (range: 99 h and 34 min to 141 h and 59 min). Mean running speed is presented in Fig. 1 . The second part (mid to post) of the race was run 32% slower than the first (pre to mid) part (flat equivalent speed: 6.1 Ϯ 1.0 vs. 4.05 Ϯ 1.0 km/h, respectively, P Ͻ 0.001). The range of exercise intensity is estimated between 40 and 50% of the velocity associated with V O 2 max . Body mass did not change during the MUM (72.2 Ϯ 6.4, 71.0 Ϯ 6.3, and 72.3 Ϯ 7.0 kg at pre, mid, and post, respectively). Systolic blood pressure remained unchanged (132 Ϯ 9, 125 Ϯ 8, and 127 Ϯ 10 mmHg), whereas diastolic blood pressure decreased from pre to mid (P Ͻ 0.01) and then remained constant (80 Ϯ 6, 71 Ϯ 8, and 76 Ϯ 8 mmHg). SVR diminished from pre to mid (P Ͻ 0.001) and then increased at post (P Ͻ 0.05) but remained lower than baseline values (P Ͻ 0.001) (17.9 Ϯ 2.1, 12.3 Ϯ 3.9, and 14.1 Ϯ 2.7 AU).
Cardiac morphological parameters. Morphological parameters for LA, RA, and ventricles and changes (in percentages) from baseline are shown in Fig. 2A . No significant differences were obtained midrace. However, at the end of the race we observed a significant enlargement of all cardiac chambers from 12 to 19% compared with baseline values.
LV and RV diastolic function. Mean LV and RV parameters of diastolic function are presented in Table 2 and individual data of LV EDV in Fig. 2B . Peak E increased progressively but reached statistical significance at post only. Individual data at pre, mid, and post of peak E are exposed in Fig. 2B . Peak A was increased at mid and returned to baseline values at post. Peak S of pulmonary venous flow increased at mid and then remained stable, whereas peak D and peak A remained unaffected by the race. E mean and A mean from tissue Doppler imaging were unaltered during the race. Longitudinal diastolic strain rate was increased at mid and then remained stable. Apical circumferential diastolic strain rates and also rotational and untwisting rates slightly increased during the race.
Transtricuspid Doppler evaluation indicated that RV peak E t was similar at mid and post (but tended to be increased midtest, P ϭ 0.14). Peak A t was increased midrace compared with baseline data. Peak E RV and peak A RV at the level of the free wall increased regularly from pre to post. IVC diameter progressively increased, without reaching statistical difference (1.98 Ϯ 0.39, 2.15 Ϯ 0.39, and 2.28 Ϯ 0.47 cm; P ϭ 0.16). Correlation between pre-post changes in SV, peak E, and changes of diastolic function parameters are presented in Table 3 . Significant correlations were found between changes in SV and peak E, and between changes in peak E and changes in LV EDV, RV EDA, RA EDA, and IVC diameter.
LV and RV systolic function. LV and RV parameters of systolic function are presented in Table 4 . SV progressively increased from pre-to postrace (Fig. 2B) . HR was increased at mid but returned to baseline values at the end of the race (Fig. 3) . Consequently, cardiac output tended to increase at mid (P ϭ 0.03) and then significantly decreased from mid to post. Similarly, LV systolic strain rates, basal circumferential strain rates, and rotational rates were increased at mid and decreased from mid to post, but only basal rotational rates reached statistical significance (Fig. 3) . EF and LV strains, rotations, and peak twist remained unchanged at mid and post compared with baseline values.
Similar results were obtained on RV function since FAC and longitudinal strain of the free wall remained constant from preto postrace. Peak S RV increased from pre to post and then remained unchanged, whereas TAPSE progressively increased from pre-to postrace.
DISCUSSION
Although previous studies evaluated cardiac function following endurance exercise such as marathons, ironman triathlons, or MUMs (7, 20, 22, 28, 42) , the present study is the first to investigate alterations in cardiac function induced by a MUM Ͼ100 h (i.e., during several days) and the first to include a measurement performed during the event. We observed that a MUM run over 4 -7 days induced 1) a specific and progressive increase of SV from pre-to postrace concomitant with an increase in diastolic filling and 2) a biphasic adaptation of HR, LV strain rates, with an initial increase from pre-to midrace and a return to baseline values from mid-to postrace.
Specific and progressive increase of SV and diastolic filling during the race. In contrast to previous studies on shorter ultraendurance events (29, 35) , our results did not show echocardiographic signs of exercise-induced LV or RV fatigue after several days of running. One of the major results was a progressive increase of SV from pre-to postrace. At midrace (148 km; 47 Ϯ 7 h), SV was greater than at prerace, an observation in accordance with one of our previous studies after 38 h of running (39) . Conversely, after shorter-duration exercises, SV was generally decreased (26, 29, 35, 42) . Of note, consequently to the higher SV, we observed a greater cardiac output at mid-and posttest. In contrast, after shorterduration races, cardiac output was generally maintained because the higher HR was counterbalanced by a decreased SV (26, 29) . The underlying mechanisms responsible for this specific increase in SV observed after the TDG represented one major concern of the present study. Mechanisms depend on a complex interplay between numerous factors involved in alterations in systolic and/or diastolic function. EF, LV strains, and peak twist were unchanged from pre-to postrace, suggesting that systolic responses did not explain the continuous increase of SV. One underlying mechanism taking part in the increase in SV could be the drop in afterload, as suggested by the strong correlations observed between changes in SVR and changes in SV from pre-to postrace. Moreover, the increase in SV was paralleled by a progressive augmentation in early diastolic filling (mitral peak E), and significant correlations Values are means Ϯ SD. Significant differences: *P Ͻ 0.016, **P Ͻ 0.01, and ***P Ͻ 0.001, different from prerace; † † P Ͻ 0.01, different from midrace. Data are Pearson's correlation coefficients. *Correlations reached statistical significance. We did not show the correlation between stroke volume (SV) and systemic vascular resistance (SVR) because there is a collinearity between them. LV, left ventricle; EDV, end-diastolic volume; RV, right ventricle; EDA, end-diastolic area; LA, left atrium; IVC, inferior vena cava; SrL-dia, diatolic longitudinal strain rate; UT, untwisting.
were found between pre-post percentage changes of peak E and SV. These findings strongly support the role of diastolic filling in the increase of SV. They contrast with the adaptation observed after shorter-duration races where diastolic filling was usually depressed (26, 29, 30, 35, 42) .
The understanding of the physiological responses responsible for this increase in LV filling remains incomplete. Regarding less load-dependent indexes of LV relaxation (6, 21, 40) , diastolic longitudinal strain rate was slightly increased, whereas E mean and untwisting rate were unchanged. In contrast, LV EDV, RV EDA, LA EDA, and RA EDA were significantly increased, and we found significant correlations between prepost percentage changes in peak E and LV EDV, RV EDA, and RA EDA. Taken together, these results do not speak in favor of an increase in LV intrinsic relaxation but strongly support the link between increased cardiac load and diastolic filling. Such alterations were not observed after one day of running, where LV end-diastolic diameter was either decreased (5, 29, 35) or unchanged (39) .
A progressive PV expansion might explain these observations. Indeed, exposure to one exercise bout can increase PV by as much as 10 -12% within 24 h (8). In collaboration with our research group, Robach et al. reported a PV expansion of 20 -25% after a MUM of 38 h using the CO rebreathing method (33) . Such hemodynamic alterations were also observed after ultraendurance exercise (i.e., 96 -106 h) (16) . Of note, subjects were exposed regularly to altitudes higher than 2,000 meters (25 passes were higher than 2,000 m). Despite the fact that PV remains unchanged after a few days at moderate altitude (36) , one cannot completely rule out that the exposure to moderate altitude during the race might have influenced the autonomic regulation of the heart and/or the circulating fluid volumes. After the race, peak S from pulmonary venous flow and IVC diameter were increased, and we observed a correlation between pre-post percentage changes of IVC diameter and LV peak E (P Ͻ 0.01). These findings strengthen the hypothesis that an increase of venous return mediated by a PV expansion was one of the key elements of the increased diastolic filling in both ventricles.
Biphasic responses of HR and systolic strain rates. At midrace, resting HR was increased, in agreement with data obtained after various race durations (5, 26, 29, 30, 35, 42) . However, it decreased from mid-to postrace, returning to near baseline values. To our knowledge, this is the first study reporting such a pattern of HR adaptation during a MUM. Recently, Mattsson et al. showed a late cardiovascular drift with a decrease of HR from 6 to 24 h during long-duration exercise performed at a constant workload (17) . Several factors may explain the decrease of HR from mid-to postrace. First, it could be due to the large deceleration throughout the race; i.e., Values are means Ϯ SD. TAPSE, tricuspid annular plane systolic excursion. Significant differences: *P Ͻ 0.016, **P Ͻ 0.01, and ***P Ͻ 0.001, different from prerace; †P Ͻ 0.016 and † † † P Ͻ 0.001, different from midrace.
the 32% decrease in running speed in the second part of the race leading to a lower workload. Second, HR could be decreased consequently to the greater SV to adapt cardiac output. However, we found no significant correlation between changes in HR and SV. Third, a desensitization of ␤-adrenergic receptors after prolonged exposure to elevated catecholamine (27) could contribute to the decrease in HR. If present, the downregulation should decrease cardiac function (i.e., cardiac fatigue), but it could be masked by exercise-induced loading alterations (i.e., increased preload and decreased afterload). Exercise-induced cardiac ␤-adrenergic receptor desensitization was controversial after 4 h of exercise (9, 38), whereas Kiuchi et al. showed a downregulation of ␤-adrenergic receptors after one week of continuous high pacing (i.e., tachycardia) (12) . However, to our knowledge, no data are available regarding alterations of ␤-adrenergic receptors after such long distance MUMs. We also observed a biphasic adaptation of systolic strain rates and S mean similar to the biphasic adaptation of HR, putting in question the relationship between these parameters. Previous studies (41) reported an unchanged systolic strain rate with an increased HR through atrial pacing, whereas an increase was reported after a dobutamine infusion. It is well known that catecholamine levels increase during effort (9), and Bahr et al. found that plasma catecholamines were still increased after 2 h of exercise (3) . Thus, the chronotropic and inotropic effects of catecholamines are likely to explain the parallel increase of both HR and systolic strain rates at midrace. The decrease of systolic strain rates from mid-to postrace may be explained by the lower contractility related to the lower HR induced by ␤-adrenergic receptor desensitization (9) .
Clinical relevance. An expert consensus of the European Association of Cardiovascular Imaging defined cardiac fatigue as a transient LV dysfunction following long-duration exercises (40) . Even if the benefits of physical activity on cardiac function are recognized, intense endurance exercises may not always be healthy because cardiac fatigue may occur after prolonged exercise. The strength of the present paper is to provide new evidence that cardiac consequences of a MUM of several days such as the TDG are very different from those observed after marathons or long-distance triathlons. The range of exercise intensity is estimated between 40 and 50% of the velocity associated with V O 2 max . It partly explains the specific results in the present study, which differ from shorter races with exercise intensity of 65-85% that have shown transient cardiac dysfunction. These new findings should be taken into account when defining the EICF. They are particularly of interest since such specific races have seen their popularity substantially growing among athletes over the last decade.
Study limitations. This exploratory study was carried out on 15 runners due to numerous dropouts during the race. It was impossible to assess the cardiovascular responses of the athletes who stopped the race (e.g., dropout) since the duration of their transport to the echocardiographic station would have been longer than the 30 -45 min requested for comparison with the finishers. Therefore, we did not investigate if the cardiac adaptations of the dropouts were different from those of the participants who finished the race. Furthermore, a continuous measurement of HR during this MUM is difficult because wearing a chest belt for such duration is highly uncomfortable to the runner. Moreover, pre-, mid-, and postevaluations were performed at different times of the day and at different altitudes (i.e., 1,224, 322, and 1,519 m, respectively). However, because of the flat shape of the oxyhemoglobin dissociation curve at the higher PO 2 values (e.g., lower altitude), changes in Pa O 2 above 60 mmHg do not have large effect on the arterial O 2 saturation ) † ** Fig. 3 . Individual values (black lines) and mean value (red line) of heart rate (HR) and LV systolic strain rates demonstrating a biphasic adaptation. Src, circumferencial strain rate; SrL, longitudinal strain rate; RotR, rotational rate. Significant differences: *P Ͻ 0.016, **P Ͻ 0.01, and ***P Ͻ 0.001, different from prerace; † P Ͻ 0.016 and † † † P Ͻ 0.001, different from midrace.
(Sa O 2 ) (43). Thus, from sea level to 2,000 meters, the decrease in PO 2 impacts to a small extent Sa O 2 . Therefore, it is unlikely that altitude might have altered per se to a large extent the cardiac functions. Finally, an assessment of markers of myocardial injury through cardiac troponin quantification (1) and an evaluation of PV would have allowed a better characterization of the involved mechanisms; however, blood sampling at midrace was not allowed for safety reasons.
In conclusion, the current study provides insight into cardiovascular responses during the world's most challenging MUM. To our knowledge, this is the first study to report a progressive augmentation of diastolic filling, SV, and LV and RV volumes based on a unique experimental design with three time points over Ͼ100 h running/walking. We also observed a biphasic adaptation of HR and myocardial strain rates with an increase from pre-to midrace and with values returning near to baseline at postrace. These data demonstrated that, compared with shorter exercise such as marathons, very-long-duration races do not induce cardiac dysfunction probably thanks to a greater diastolic filling related to an increased venous return. A better comprehension of the involved underlying mechanisms and the clinical consequences of increased cardiac load in runners completing numerous MUMs are important issues for future investigations.
